Associated Papers
A Role for Caveolin-3 in the Pathogenesis of Muscular Dystrophies.
Pradhan BS et al.
International Journal of Molecular Sciences, 2020
Immunofluorescence-Based Analysis of Caveolin-3 in the Diagnostic Management of Neuromuscular Diseases.
Roos A et al.
Methods in Molecular Biology (clifton, N.j.), 2020
Biochemical and pathological changes result from mutated Caveolin-3 in muscle.
González Coraspe JA et al.
Skeletal Muscle, 2018
The role of CAV3 in long-QT syndrome: clinical and functional assessment of a caveolin-3/Kv11.1 double heterozygote versus caveolin-3 single heterozygote.
Hedley PL et al.
Circulation. Cardiovascular Genetics, 2013
Caveolinopathies: from the biology of caveolin-3 to human diseases.
Gazzerro E et al.
European Journal of Human Genetics : Ejhg, 2010
Rippling muscle disease and cardiomyopathy associated with a mutation in the CAV3 gene.
Catteruccia M et al.
Neuromuscular Disorders : Nmd, 2009
Two novel CAV3 gene mutations in Japanese families.
Sugie K et al.
Neuromuscular Disorders : Nmd, 2004
Homozygous mutations in caveolin-3 cause a severe form of rippling muscle disease.
Kubisch C et al.
Annals of Neurology, 2003
Consequences of a novel caveolin-3 mutation in a large German family.
Fischer D et al.
Annals of Neurology, 2003
Select a paper to view details